Highlighting new phylogenetic specificities of Crohn's disease microbiota

• Published in: Inflammatory bowel diseases 2011-01, Vol.17 (1), p.185-192
• Main Authors: Mondot, S., Kang, S., Furet, J.P., Aguirre de Carcer, D., McSweeney, C., Morrison, M., Marteau, P., Doré, J., Leclerc, M.
• Format: Article
• Language: English
• Subjects: 16S rRNA; Adolescent; Adult; Aged; Aged, 80 and over; Agricultural sciences; Bifidobacterium bifidum; Bioinformatics; Case-Control Studies; Crohn Disease - diagnosis; Crohn Disease - genetics; Crohn Disease - microbiology; Crohn's disease; dysbiosis; Enterococcus faecium; Escherichia coli; Eubacterium rectale; Faecalibacterium prausnitzii; Female; Gastrointestinal tract; Gastrointestinal Tract - microbiology; Gastrointestinal Tract - pathology; Humans; Inflammatory bowel diseases; Intestine; Life Sciences; Male; Metagenome - genetics; microarray; microbiota; Middle Aged; Phylogeny; Polymerase chain reaction; Primers; Probes; Prognosis; Proteobacteria; Ruminococcus; Young Adult
• ISSN: 1078-0998; 1536-4844; 1536-4844
• DOI: 10.1002/ibd.21436

Background: Recent studies suggest that gastrointestinal (GI) microbes play a part in the pathogenesis of Crohn's disease (CD). Methods: Fecal samples were collected from 16 healthy individuals and 16 CD patients (age‐ and sex‐matched). The DNA extracted from these samples were subjected to two different methods of microbiome analysis. Specific bacterial groups were quantified by real‐time polymerase chain reaction (PCR) methods using primers designed using a high‐throughput in‐house bioinformatics pipeline. The same DNA extracts were also used to produce fluorescently labeled cRNA amplicons to interrogate a custom‐designed phylogenetic microarray for intestinal bacteria. Results: Even though the intersubject variability was high, differences in the fecal microbiomes of healthy and CD patients were detected. Faecalibacterium prausnitzii and Escherichia coli were more represented in healthy and ileal CD patients, respectively. Additionally, probes specific for Ruminococcus bromii, Oscillibacter valericigenes, Bifidobacterium bifidum, and Eubacterium rectale produced stronger hybridization signals with the DNA samples from healthy subjects. Conversely, species overrepresented in CD patients were E. coli, Enterococcus faecium, and species from the Proteobacteria not normally found in the healthy human GI tract. Furthermore, we detected “healthy specific” molecular species or operational taxonomic units (OTUs) that are not closely related to any known species (Faecalibacterium, Subdoligranulum, and Oscillospora species), indicating that the phylogenetic dysbiosis is broader than at strain or species level. Conclusions: These two techniques of microbiome analysis provided a statistically robust new picture of the dysbiosis in fecal microbiota from ileal CD patients. Specifically, we identified a set of six species discriminant for CD, which provides a preliminary diagnostic tool. (Inflamm Bowel Dis 2011;)